-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
-
Multifaceted Approach Needed for Early Lung Cancer Detection
Analyses by Drs. Matthew P. Smeltzer and Raymond U. Osarogiagbon show nodule and LDCT lung cancer screening programs may be serving two distinct populations with only moderate overlap.
-
Increasing Evidence Demonstrates the Usefulness of ctDNA
LALCA participants recap how the field of liquid biopsy continues to grow—from new biomarkers to new frontiers in early cancer detection.
-
Education Award Recipients Recognized at Latin America Conference
During the Closing Ceremony, five early-career, trainee, or resident investigators were honored for presenting at LALCA 2023.
-
Committee Update: Advocates Offer Unique Support to Members, Help Investigators Understand Patients
Patient Advocates Committee Chair Jill Feldman said ensuring the patient voice is present in research helps to improve the work being done to reduce the burden of lung cancer worldwide.
-
In Brief for Feb. 8, 2023
Dr. Carolyn Dresler Joins Action on Smoking and Health (ASH) Board of Trustees; Novel Liquid Biopsy Assay for Lung Carcinoma Detection Receives FDA Breakthrough Device Designation.
-
Latin America Conference Attendees Gather Face-to-Face for First Time Since 2019
As LALCA 2023 gets under way in Montevideo, Uruguay, hear from chairs Drs. Luis Ubillos, Mario Varangot, Clarissa Mathias, and Carlos Barrios about the science that will be discussed.
-
Despite Evidence of Benefit, Developing Countries Often Lack Routine Lung Cancer Screening Practices
Expert panel to discuss challenges and opportunities for increasing LDCT screening in Latin America during LALCA 2023.
-
Presidential Symposium Features Best of Abstract Submissions
Highlighted studies explore the association of TP53 mutations with inferior prognosis in NSCLC patients of African ancestry, the possibilities for next-generation sequencing to guide therapy, and the use of a 12-gene expression panel to predict treatment benefit.
-
In Brief for January 25, 2023
China approves mobocertinib for patients with EGFR Exon20 insertion+ NSCLC; Deadline approaching for IASLC 2023 Lectureship and Distinguished Service Award Nominations.
-
IASLC Announces New JTO CRR Editor-in-Chief
Dr. Emily Stone will succeed JTO Clinical and Research Reports founding editor Dr. Alex A. Adjei, who will remain editor-in-chief of the Journal of Thoracic Oncology.